As artificial intelligence (AI) continues to reshape Medical Affairs and the Medical Science Liaison (MSL) profession, one question is becoming increasingly important across the industry: Can someone effectively train MSLs without ever having worked as an MSL or led an MSL team? Part of what prompted this article was the growing number of individuals on LinkedIn and other … [Read more...]

Welcome back, MSL Journal Readers! As we move into the summer season, I am delighted to share this latest online edition of The MSL Journal – a collection of insights, practical strategies, and perspectives designed to support excellence in the evolving Medical Science Liaison role and, more broadly, the medical affairs profession. The role of the MSL continues to expand … [Read more...]

Few topics in Medical Affairs generate as much recurring discussion as the terminology used to describe highly influential physicians and health care professionals (HCPs). While some organizations have attempted to move away from the term “Key Opinion Leader” (KOL) in favor of alternatives such as “Thought Leader” or “External Expert,” the term KOL remains deeply embedded … [Read more...]

Abstract Background: Effective Medical Science Liaison (MSL) performance measurement requires a comprehensive framework that captures the multidimensional nature of MSL contributions to pharmaceutical organizations and healthcare systems. Objective: To establish a three-pillar framework for MSL performance measurement encompassing value creation indicators, patient … [Read more...]

What’s your first reaction when challenged by a KOL? What is your gut reaction? The art of being an MSL involves turning uncomfortable moments into meaningful insights valuable to your company and, more so, to the physician’s patients. Gaining a deeper understanding of the actual concern can strengthen your KOL relationships by turning this “objection” into a meaningful … [Read more...]

Introduction It’s launch time. The heavy lifting of R&D and interaction with HCPs, regulators, and patient groups has been concluded, and a coordinated ‘battle plan’ has been signed and sealed. Time to exhale? Far from it. Product launches require a particular intensity and commitment to survive a precarious period that is still being shaped by changing demands and … [Read more...]

A Case Study Featuring Dr. Maria Abunto and Dr. Justin D. Pykare Published in collaboration with AMSLE and RAMA Introduction The Medical Science Liaison (MSL) role is evolving toward strategic scientific collaboration beyond just relationship building. The complex healthcare landscape demands that field insights be systematically captured, synthesized, and translated … [Read more...]

The role of the MSL (Medical Science Liaison) has always required an uncommon combination of: Scientific depth, relational intelligence, and strategic agility. However, as the volume of publications grows, the availability of RWD (Real World Data) becomes increasingly overwhelming, and KOL expectations become more complex, even the most experienced MSL teams face a shared … [Read more...]

Abstract Patient engagement is widely recognized as a priority across the life sciences industry. Yet many organizations still struggle to translate patient insights into meaningful operational decisions. Medical Affairs professionals sit at a unique intersection of science, clinical practice, and patient experience. This article explores how Medical Affairs/MSLs can move … [Read more...]

Medical Affairs has long been defined by scientific credibility. Accuracy, balance, and compliance remain essential foundations. However, in a healthcare environment shaped by data overload, increasing system complexity, and evolving stakeholder expectations, scientific excellence alone is no longer enough. The question facing Medical Affairs today is not what we know, but … [Read more...]

Overview Cancer care across Africa is experiencing rapid changes. Our recent discussion with frontline clinicians in Cameroon, a West Central African country, highlighted both urgent current challenges and the momentum toward meaningful progress. We held a virtual roundtable with physicians and nurses from various parts of Cameroon’s cancer ecosystem, and several key themes … [Read more...]

Disclosure: The views, thoughts, and opinions expressed in this article belong solely to the author and do not necessarily reflect the views or positions of any other individual, organization, employer, or company associated with them. Introduction Cell and gene therapies (CGT) have redefined what is possible in medicine, and, in doing so, it has challenged what is … [Read more...]

“Ladies and gentlemen, the animal health market has exploded”. Over the past few decades, the animal health industry has undergone a profound transformation, particularly within the companion animal segment. In developed countries, the strengthening of the animal-human bond has resulted in increased attention to animal welfare and a growing willingness of pet owners to … [Read more...]

The Evolving Role and Dynamic Capabilities of the Medical Science Liaison (MSL) The role of the MSL has evolved significantly within the modern pharmaceutical and MedTech industries. Once seen as a predominantly reactive support function, Medical Affairs is now widely recognized as a strategic business partner that translates scientific insights into actionable go-to-market … [Read more...]

Introduction In recent years, few areas of biomedical science have generated as much excitement as the study of the human gut microbiome. Once viewed simply as a collection of commensal organisms inhabiting the gastrointestinal tract, the microbiome is now understood to be a dynamic and complex ecosystem that profoundly influences human health. Significant advances in … [Read more...]

Introduction The reason I chose to work as a Medical Science Liaison (hereafter MSL) was never just the science. Coming from a background in nursing science, I have always been driven by the question of how scientific advances translate into better care for patients. Having now worked in the pharmaceutical industry for some time, I have learned that being an effective MSL … [Read more...]

Medical Affairs generates enormous value. Every day, Medical Science Liaisons have high-quality scientific conversations with clinicians who shape practice, influence peers, and test evidence against reality. Few functions in pharma have this level of access, trust, and depth. And yet, much of the potential value from these interactions is quietly lost. Not because MSLs … [Read more...]

Disclaimer: The ideas discussed in this manuscript belong to the authors and do not represent views or endorsements of their employers Introduction: Medical Affairs in the Age of AI We are living in a transformative moment in medical affairs. For the first time, the instantaneous availability of data and information allows for the strategic integration of real-world … [Read more...]